Maple syrup urine disease: it has come a long way

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Maple syrup urine disease (MSUD) is a rare, inherited metabolic disorder characterized by a defect in the mitochondrial branched-chain alpha-ketoacid (BCKD) dehydrogenase complex.
• Genetic mutations in the BCKD complex subunits (E1 alpha, E1 beta, E2, E3) explain the heterogeneity observed in MSUD patients.
• Understanding the molecular basis of these mutations is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To investigate the role of bacterial chaperonins GroEL/GroES in the folding and assembly of the BCKD complex's E1 decarboxylase component.
• To elucidate the impact of specific E1 alpha mutations, such as Y393N-alpha found in Mennonite MSUD patients, on protein assembly and stability.
• To assess the potential of gene therapy for correcting E1 alpha-deficient (type IA) MSUD.

Main Methods:

• Utilized bacterial chaperonins GroEL and GroES to study the folding and assembly of the E1 decarboxylase component of the BCKD complex in Escherichia coli.
• Employed pulse-chase labeling experiments to analyze the assembly and degradation of E1 alpha and E1 beta subunits in MSUD patient-derived cells.
• Performed retrovirus-mediated transduction of lymphoblasts from an MSUD patient with a normal E1 alpha cDNA to evaluate gene therapy efficacy.

Main Results:

• Bacterial chaperonins GroEL/GroES were found to promote the folding and assembly of the E1 decarboxylase component.
• A specific E1 alpha mutation (Y393N-alpha) was identified to impede the assembly of the mutant E1 alpha subunit with normal E1 beta, leading to rapid degradation of E1 beta.
• Retroviral delivery of normal E1 alpha cDNA successfully restored BCKD activity and stabilized E1 beta through proper assembly in MSUD patient lymphoblasts.

Conclusions:

• The study demonstrates that bacterial chaperonins can facilitate the assembly of the BCKD complex, offering insights into protein folding mechanisms.
• Assembly defects caused by specific E1 alpha mutations lead to the degradation of essential BCKD complex subunits, contributing to MSUD pathogenesis.
• Gene therapy using retrovirus-mediated transduction of E1 alpha cDNA is a feasible approach for stable correction of type IA MSUD, paving the way for clinical applications.